SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-085200
Filing Date
2023-11-09
Accepted
2023-11-09 16:01:53
Documents
49
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_phoenix.htm   iXBRL 10-Q 605183
2 CERTIFICATION f10q0923ex31-1_phoenix.htm EX-31.1 14874
3 CERTIFICATION f10q0923ex31-2_phoenix.htm EX-31.2 14551
4 CERTIFICATION f10q0923ex32-1_phoenix.htm EX-32.1 6491
5 CERTIFICATION f10q0923ex32-2_phoenix.htm EX-32.2 6509
  Complete submission text file 0001213900-23-085200.txt   4058901

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pbax-20230930.xsd EX-101.SCH 49502
7 XBRL CALCULATION FILE pbax-20230930_cal.xml EX-101.CAL 21729
8 XBRL DEFINITION FILE pbax-20230930_def.xml EX-101.DEF 238642
9 XBRL LABEL FILE pbax-20230930_lab.xml EX-101.LAB 404207
10 XBRL PRESENTATION FILE pbax-20230930_pre.xml EX-101.PRE 240516
43 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_phoenix_htm.xml XML 396366
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40877 | Film No.: 231392169
SIC: 2836 Biological Products, (No Diagnostic Substances)